|Videos|August 2, 2021
Roundtable: Synthetic Control Arms and Regulatory/HTA Requirements
Author(s)Parexel
Advertisement
A roundtable discussing the opportunities that synthetic control arms offer for patients and product developers, and how to overcome potential barriers with the use of this burgeoning clinical trial model.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Ypsomed Announces New U.S.-Based Manufacturing Site in North Carolina
2
Pharmaceutical Executive Daily: Most Favored Nation Order's Evolving Landscape
3
Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer Programs
4
AstraZeneca to Announce Deal with Trump Administration: Report
5
